Log in or Sign up for Free to view tailored content for your specialty!
Melanoma/Skin Cancer News
Lifileucel approval the start of a ‘glorious future’ for cell therapy in solid tumors
It took more than 35 years for tumor-infiltrating lymphocytes, which Steven A. Rosenberg, MD, PhD, and colleagues first reported on in 1988 for the treatment of advanced melanoma, to progress enough to gain FDA approval.
Cedars-Sinai Cancer appoints director of melanoma research
Bin Zheng, PhD, has been appointed director of melanoma research in the department of biomedical sciences at Cedars-Sinai Cancer.
Dupilumab treatment for atopic dermatitis linked to cutaneous T-cell lymphoma development
A new study finds that dupilumab is associated with an increased risk for cutaneous T-cell lymphoma in patients taking the drug for atopic dermatitis.
Log in or Sign up for Free to view tailored content for your specialty!
New data ‘offer some hope’ that checkpoint inhibitors may be safe for pregnant women
Use of immune checkpoint inhibitors for pregnant women with cancer may be safer than previously thought, according to study results published in JAMA Network Open.
FDA grants accelerated approval to Enhertu for adults with advanced solid tumors
The FDA granted accelerated approval to fam-trastuzumab deruxtecan-nxki for the treatment of adults with unresectable or metastatic HER2-positive solid tumors who received previous systemic therapy and lack additional treatment options.
Yes, you can sunburn during an eclipse: Dermatologist discusses skin safety for rare event
When viewing the solar eclipse on April 8, individuals in the United States should not only protect their eyes, but also their skin.
AACR to honor Pfizer, Albert Bourla, PhD, for service to cancer science and medicine
Pfizer Inc. and its chairman/CEO, Albert Bourla, PhD, will be awarded the 2024 AACR Outstanding Achievement Award for Service to Cancer Science and Medicine during the American Association for Cancer Research Annual Meeting in San Diego.
Untreated obstructive sleep apnea raises risk for poor prognosis in melanoma
Among patients with melanoma, untreated moderate to severe obstructive sleep apnea increased the risk for poor long-term prognosis of skin cancer, according to results published in CHEST.
Older adults, men at increased risk for second primary melanoma diagnosis
Following a first primary invasive melanoma diagnosis, older adults and men may experience a second case sooner than other patients, according to a study.
Guidelines: Toxicity management vital with tumor-infiltrating lymphocytes
Clinicians treating patients with tumor-infiltrating lymphocytes should closely monitor toxicities associated with interleukin-2 and halt administration of the drug if necessary, according to the first guidelines regarding the therapy.
-
Headline News
2024 State of the Air report: 39% of Americans breathe polluted, unhealthy air daily
April 24, 20246 min read -
Headline News
Federal Trade Commission bans most noncompete agreements
April 24, 20243 min read -
Headline News
Genes may play role in heart attack risk during stressful times
April 24, 20242 min read
-
Headline News
2024 State of the Air report: 39% of Americans breathe polluted, unhealthy air daily
April 24, 20246 min read -
Headline News
Federal Trade Commission bans most noncompete agreements
April 24, 20243 min read -
Headline News
Genes may play role in heart attack risk during stressful times
April 24, 20242 min read